Casado MA
Farmacoeconomía de las Terapias Biológicas en las Enfermedades Inflamatorias Crónicas. Punto de Vista del Técnico en Farmacoeconomía
I Simposium Nacional sobre Terapias Biológicas. Córdoba, España. 13-14 ene 2006
Casado Gómez MA, Alvarez-Rubio L, Miró Manero S, Mariño Hernández EL, Buti Ferret M
Análisis de impacto presupuestario en el tratamiento de la hepatitis por virus C en un hospital
Farm Hosp. 2006;30:291-9
Buti M, Casado MA, Calleja JL, Salmerón J, Aguilar J, Rueda M, Esteban R
A Cost-effectiveness analysis of two oral antiviral drugs for treatment of HBeAg-negative chronic hepatitis B patient
Aliment Pharmacol Ther. 2006;23:409-19
Buti M, Wong J, Casado MA, Esteban R
Quality of life and cost-effectiveness of anti-HCV therapy in HIV-infected patients
J Hepatol. 2006;44(Suppl 1):S60-S64
Moreno S, Casado MA, Domingo P, Llibre JM, Martínez E, Miralles C, Santos J, Pérez-Elías MJ, Alvarez ML
Tenofovir DF is associated with decreased HIV-related healthcare costs in HIV-1-infected heavily pre-treated patients with nucleoside reverse transcriptase inhibitors-related toxicity
10th European AIDS Conference / EACS. Dublin, Ireland. 17-20 nov 2005
Moreno S, Casado MA, Domingo P, Llibre JM, Martínez E, Miralles C, Santos J, Pérez-Elías MJ, Sánchez de la Rosa R
Cost of the NRTI-related toxicities in HIV-1-infected heavily experienced patients
7th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. Dublin, Ireland. 13-16 nov 2005
Wong JB, Buti M, Casado MA, Fosbrook L, Soriano V, Esteban R
Cost-effectiveness of peginterferon alfa-2b plus ribavirin for chronic hepatitis C in HIV-HCV co-infected patients
56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) and awarded a Presidential Poster of Distinction. San Francisco, California, EEUU. 11-15 nov 2005
Buti M, Casado MA, Calleja JL, Salmerón J, Aguilar J, Rueda M, Esteban R
Long-term treatment with adefovir dipivoxil is more cost-effective than lamivudine for HBeAg-negative patients with chronic hepatitis B
56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). San Francisco, California, EEUU. 11-15 nov 2005
Casado MA
The pharmacoeconomics of anti-HBV treatments. Monothematic conference: From viral pathobiology to the treatment of hepatitis B virus infection
Istanbul, Turkey. 6-8 oct 2005
Casado MA, Garriga R, Pla R